Records Management

PRODUCTS

  • Allogeneic CAR-T Cells Vs Autologous

    Chimeric antigen receptor (CAR) T cell therapy has emerged as one of the major breakthroughs in cancer immunotherapy in the last decade. Clinical trials with autologous CAR-T cells have shown very promising results and led to the approval of numerous CAR-T cell therapies.

  • Multicolor Multiphoton gets you closer to the truth

    The combination of multiple distinct fluorescent labels is increasingly used to study dynamic interaction and spatial relationships among cells and molecules. The goal is to understand a myriad of complex biological events, such as cellular connectivity, cell phenotyping, protein interaction or co-expression, and co-localization. Scaling up such studies to whole organs or tissues requires suitable large-volume multicolor microscopy methods. DIVE and STELLARIS have now merged to provide you with the power of flexible multicolor multiphoton imaging. Furthermore, you can expand the potential of your experiments with additional label-free imaging capabilities.

    Seamlessly integrated into the confocal software interface, STELLARIS 8 DIVE multiphoton microscope offers the benefits of high speed and excellent navigation so that dynamic processes in complex samples can be studied with ease. STELLARIS 8 DIVE – A rainbow of possibilities for your research.

  • Find the missing links

    The modular DMi8 inverted microscope is the heart of the DMi8 S platform solution. For routine to live cell research, the DMi8 S platform is a complete solution. Whether you need to precisely follow the development of a single cell in a dish, screen through multiple assays, obtain single molecule resolution, or tease out behaviors of complex processes, a DMi8 S system will enable you to see more, see faster, and find the hidden.

    • See more – Increase your viewing area up to 10,000x
    • See faster – Experiments up to 5x faster
    • See the hidden – Activate, ablate, and bleach within one experiment
  • As a top Clinical Research Organization, ProPharma brings over 20 years of experience, innovation, personalization, and adaptability to Sponsors’ studies and research.

  • Germfree’s compliant modular compounding pharmacies offers non-hazardous and hazardous drug compounding within our established modular platform. It enables hospital pharmacies to manage surges, maintain patient support during renovations, and enhance efficiency with Germfree’s cutting-edge modular hospital compounding pharmacy.

WHITE PAPERS AND CASE STUDIES

NEWS